137 related articles for article (PubMed ID: 10850524)
1. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.
Gajjar DA; LaCreta FP; Kollia GD; Stolz RR; Berger S; Smith WB; Swingle M; Grasela DM
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):76S-86S. PubMed ID: 10850524
[TBL] [Abstract][Full Text] [Related]
2. A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men.
Gajjar DA; LaCreta FP; Uderman HD; Kollia GD; Duncan G; Birkhofer MJ; Grasela DM
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):49S-58S. PubMed ID: 10850521
[TBL] [Abstract][Full Text] [Related]
3. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D
Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
[TBL] [Abstract][Full Text] [Related]
4. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens.
Richard GA; Mathew CP; Kirstein JM; Orchard D; Yang JY
Urology; 2002 Mar; 59(3):334-9. PubMed ID: 11880065
[TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment.
Grasela DM; Christofalo B; Kollia GD; Duncan G; Noveck R; Manning JA; LaCreta FP
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):87S-94S. PubMed ID: 10850525
[TBL] [Abstract][Full Text] [Related]
6. Age and gender effects on the pharmacokinetics of gatifloxacin.
LaCreta FP; Kollia GD; Duncan G; Behr D; Grasela DM
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):67S-75S. PubMed ID: 10850523
[TBL] [Abstract][Full Text] [Related]
7. Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults.
LaCreta FP; Kaul S; Kollia GD; Duncan G; Randall DM; Grasela DM
Pharmacotherapy; 2000 Jun; 20(6 Pt 2):59S-66S. PubMed ID: 10850522
[TBL] [Abstract][Full Text] [Related]
8. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
Mohr JF; McKinnon PS; Peymann PJ; Kenton I; Septimus E; Okhuysen PC
Pharmacotherapy; 2005 Oct; 25(10):1303-9. PubMed ID: 16185173
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological aspect of dysglycemia in naive and diabetic rats induced by the fluoroquinolone antibacterial gatifloxacin.
Nagai M; Nagata S; Yamagishi N; Satoh H; Furuhama K
J Vet Med Sci; 2010 May; 72(5):567-73. PubMed ID: 20068268
[TBL] [Abstract][Full Text] [Related]
10. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
Kudolo GB
J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
[TBL] [Abstract][Full Text] [Related]
11. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
[TBL] [Abstract][Full Text] [Related]
12. Gatifloxacin-induced histamine release and hyperglycemia in rats.
Ishiwata Y; Yasuhara M
Eur J Pharmacol; 2010 Oct; 645(1-3):192-7. PubMed ID: 20674567
[TBL] [Abstract][Full Text] [Related]
13. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
14. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
[TBL] [Abstract][Full Text] [Related]
15. Gatifloxacin acutely stimulates insulin secretion and chronically suppresses insulin biosynthesis.
Yamada C; Nagashima K; Takahashi A; Ueno H; Kawasaki Y; Yamada Y; Seino Y; Inagaki N
Eur J Pharmacol; 2006 Dec; 553(1-3):67-72. PubMed ID: 17070519
[TBL] [Abstract][Full Text] [Related]
16. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
[TBL] [Abstract][Full Text] [Related]
17. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA
Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
[TBL] [Abstract][Full Text] [Related]
19. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]